PITX2 and atrial fibrillation: It will be challenging to directly assess LA RMP in AF patients, but our data suggested that differences in atrial RMP could explain the effectiveness of Na-channel blockers in carriers of common gene variants on chromosome 4q25 (43), although LA PITX2 levels are modulated by factors other than SNP status (Table 2) (44).